Stocks and InvestingStocks and Investing
Mon, November 7, 2022
Fri, November 4, 2022

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $10 on, Nov 4th, 2022


Published on 2024-10-27 23:56:31 - WOPRAI, Douglas Miehm
  Print publication without navigation


Douglas Miehm of RBC Capital, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $18 to $10 on, Nov 4th, 2022.

Douglas has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, August 9th, 2022